Skip to main content
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.550
-0.020 (-1.27%)
Dec 5, 2025, 4:00 PM EST - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Chimeric Antigen Receptors T Cell Therapies
10.12M
Log In
Log In
Log In
Log In
Upgrade
Chimeric Antigen Receptors T Cell Therapies Growth
496.00%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Europe
10.12M
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom, Europe and United States Growth
-
Log In
Log In
Log In
Log In
Upgrade